SCHEMBL7904391

SCHEMBL7904391

C[C@H]1CNc2c(N)cc(Cl)cc2CN1CC1CC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 5/20 0.32
OPRK1 P41145 2/20 0.32
OPRM1 P35372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7903496 0.80 SIGMAR1 (0.32) OPRD1OPRK1OPRM1
SCHEMBL7903478 0.67 PNMT (0.31)
SCHEMBL24469666 0.62 PARP1 (0.41)
SCHEMBL16268940 0.61 HTR1A (0.40) OPRD1OPRK1OPRM1
SCHEMBL7904443 0.61
SCHEMBL14582419 0.61 BRD4 (0.32)
SCHEMBL7038907 0.60 KMT2A (0.41)
SCHEMBL7896192 0.60 ALOX5 (0.30)
SCHEMBL4941638 0.58 MEN1 (0.39)
SCHEMBL7902351 0.57 OPRM1 (0.34) OPRD1OPRK1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed